HOME >> BIOLOGY >> NEWS
ORNL, Georgia's Isotron develop promising new cancer treatment

OAK RIDGE, Tenn., Jan. 30, 2003 Doctors treating incurable brain tumors and other cancers resistant to conventional therapies will soon have a new treatment available to them because of a development by Isotron of Alpharetta, Ga., and the Department of Energys Oak Ridge National Laboratory.

The advantage of the treatment, called neutron brachytherapy, is that physicians can deliver a highly concentrated dose of californium-252 neutrons to the site of a tumor instead of having to treat the tumor with conventional gamma rays, which often are not as effective. This therapy has proved particularly useful against cancers that are resistant to photon and gamma treatments, which do not kill cancer cells as effectively as do the californium-252 neutrons.

Cancers most resistant to the conventional treatments include brain tumors, melanoma, sarcoma, certain types of prostate cancer, locally advanced breast cancer, cervical cancer and cancer of the head, neck and mouth.

The progress achieved with neutron brachytherapy will enable unprecedented cancer treatment and will help physicians treat nearly 20 different types of cancer, said co-developer Rodger Martin of ORNLs Nuclear Science and Technology Division.

The key to the ORNL success is the miniaturization of the californium-252 source, which allows physicians to insert the radioisotope through a catheter directly to the tumor site.

Martin and colleagues were able to reduce the diameter of the source by more than half from the previous standard of about 2.8 millimeters. This makes it possible to reach and treat tumors that previously could only be treated with conventional photon and gamma brachytherapy or with external beam treatments. ORNL and Isotrons success is the result of many months of development and testing that began in 1999 with the signing of a three-year cooperative research and development agreement.

After reducing the diameter of the source - the wire that conta
'"/>

Contact: Ron Walli
Wallira@ornl.gov
865-576-0226
DOE/Oak Ridge National Laboratory
30-Jan-2003


Page: 1 2

Related biology news :

1. Stretch of I-40 part of ORNL, UT environmental lab initiative
2. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Wisconsin scientists develop quick botox test
5. Bronfenbrenner book sums up human development
6. Researchers develop fast track way to discover how cells are regulated
7. DuPont developing new protective suits for military, first responders
8. OutFoxed! New research may redefine late-stage cardiac development
9. Computer scientists at UH developing nurturing computers
10. Disease diagnosis, drug development focus of UH profs biochip research
11. Columbia, Stony Brook, Guidant to develop biological pacemaker based on gene & cell therapies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/11/2020)... ... May 11, 2020 , ... ... platform for patients with implanted cardiac devices. The Octagos software allows healthcare professionals ... The software greatly simplifies the management of remote transmissions and at the same ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
(Date:4/28/2020)... Fla. (PRWEB) , ... April 27, 2020 , ... ... The first-of-its-kind category-defining service was started by three teenagers with an idea to ... in the world during the time of great need and suffering, an outlet ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... , ... May 21, 2020 , ... ... clinical trials will cause long-term harm , Contrary to conventional wisdom that says ... study finds many companies will emerge from the pandemic commercially weaker, dealing ...
(Date:5/15/2020)... (PRWEB) , ... May 14, ... ... supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC ... to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollectâ„¢-EV-CC ...
(Date:5/14/2020)... ... May 12, 2020 , ... DuPont Nutrition & Biosciences (N&B) ... all personal care ingredients in Russia and Belarus. Beginning May 1, Interdisp JCS ... personal care. , The GENENCARE®OSMS product line contains a range of ...
(Date:5/9/2020)... ... ... Worldwide Business with kathy ireland® will be LIVE streaming ... Wednesday, May 13, 2020 at 8:00pm ET / PT – prime time viewings ... Techolution and Bravado Pharmaceuticals . , As leaders in their industries, ...
Breaking Biology Technology:
Cached News: